The Food and Drug Administration (FDA) is announcing a public meeting entitled “International Consortium of Cardiovascular Registriesâ€.
The purpose of the meeting is to discuss the development of an international consortium of cardiovascular registries with a broad array of interested stakeholders. The initial pilot phase of this effort will be developing relations and analysis strategies for transcatheter cardiac valve registries, with the understanding that these efforts would be expended to additional cardiovascular devices in the future.
- Date, Time and Location
- Agenda
- Registration
- Contact Us
FDA Campus Information
The meeting will be available via webcast.
[email protected].
[email protected]
Â
Â